Pfizer, BioNTech to Supply EU With Additional 200 Million Covid-19 Vaccine Doses

 Pfizer Inc. and BioNTech SE said Wednesday that they have entered into an agreement with the European Commission to supply additional 200 million doses of their jointly-developed Covid-19 vaccine.

Under the agreement, the additional doses are expected to be delivered in 2021, with an estimated 75 million doses to be supplied in the second quarter, the companies said. The European Commission has the option to request an additional 100 million doses, they said.

The new agreement comes in addition to the first supply agreement for 300 million doses which was signed in 2020. It now brings the total number of doses to be supplied to EU member states by 2021 to 500 million--extendable to 600 million if the additional doses are requested.

https://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/Pfizer-BioNTech-to-Supply-EU-With-Additional-200-Million-Covid-19-Vaccine-Doses-32459655/